CG Stock Analysis: Carlyle | NASDAQ
Asset Management | NASDAQ, USA | Market Cap: 17.492m USD | 12M Return: -21.7% | US14316J1088 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 202M
EPS Trend: 87.6%
Qual. Beats: 1
Rev. Trend: 79.4%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The Carlyle Group Inc. (CG) is a global investment firm that specializes in direct and fund-of-fund investments, spanning a wide range of strategies including leveraged buyouts, privatizations, distressed debt, venture and growth capital, mezzanine financing, and structured credit. The firm operates through four core segments: Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions, deploying capital across sectors such as industrial, aerospace and defense, healthcare, energy, financial services, technology, real estate, consumer and retail, and telecommunications. Its investment activities frequently involve management-led buyouts, recapitalizations, and turnaround situations. As one of the worlds largest private equity firms by assets under management, Carlyle serves institutional investors, sovereign wealth funds, and high-net-worth individuals, generating revenue primarily through management fees and performance-related carried interest on its investment funds.
- Fee Related Earnings margin expands across private equity and credit segments
- Distributable earnings grow as exit activity and realizations accelerate
- Share buyback program and dividend support shareholder returns
| Net Income: 363.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.07 > 0.02 and ΔFCF/TA -8.57 > 1.0 |
| NWC/Revenue: -56.09% < 20% (prev 58.74%; Δ -114.8% < -1%) |
| CFO/TA -0.07 > 3% & CFO -1.87b > Net Income 363.9m |
| Net Debt (12.2b) to EBITDA (851.6m): 14.34 < 3 |
| Current Ratio: 0.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (367.3m) vs 12m ago 0.08% < -2% |
| Gross Margin: 70.67% > 18% (prev 84.35%; Δ -13.68% > 0.5%) |
| Asset Turnover: 14.88% > 50% (prev 17.54%; Δ -2.66% > 0%) |
| Interest Coverage Ratio: 2.35 > 6 (EBIT TTM 757.5m / Interest Expense TTM 322.2m) |
| A: -0.08 (Total Current Assets 3.51b - Total Current Liabilities 5.73b) / Total Assets 28.2b |
| B: 0.03 (Retained Earnings 873.8m / Total Assets 28.2b) |
| C: 0.03 (EBIT TTM 757.5m / Avg Total Assets 26.6b) |
| D: 0.34 (Book Value of Equity 7.21b / Total Liabilities 21.0b) |
| Altman-Z'' = 0.14 = B |
| DSRI: 1.57 (Receivables 1.47b/1.04b, Revenue 3.96b/4.40b) |
| GMI: 1.19 (GM 84.35% / 70.67%) |
| AQI: 0.99 (AQ_t 0.86 / AQ_t-1 0.87) |
| SGI: 0.90 (Revenue 3.96b / 4.40b) |
| TATA: 0.08 (NI 363.9m - CFO -1.87b) / TA 28.2b) |
| Beneish M = -2.46 (Cap -4..+1) = BBB |
As of August 31, 2026, the stock is trading at USD 49.09 with a total of 1,881,190 shares traded. Over the past week, the price has changed by -0.57%, over one month by +9.00%, over three months by +9.63% and over the past year by -21.68%.
Current recommended Stop Loss: 45.40 (which is 7.5% or 2.3 ATR below the current price).
Carlyle has received a consensus analysts rating of 3.76. Therefore, it is recommended to hold CG.
- StrongBuy: 6
- Buy: 2
- Hold: 8
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 58.2 | 18.5% |
P/E Trailing = 51.1354
P/E Forward = 13.089
P/S = 6.2546
P/B = 3.3471
P/EG = 1.1589
Revenue TTM = 3.96b USD
EBIT TTM = 757.5m USD
EBITDA TTM = 851.6m USD
Long Term Debt = unknown (none)
Short Term Debt = 387.3m USD (from shortTermDebt, two quarters ago)
Debt = 14.3b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 12.2b USD (calculated: Debt 14.3b - CCE 2.04b)
Enterprise Value = 29.7b USD (17.5b + Debt 14.3b - CCE 2.04b)
Interest Coverage Ratio = 2.35 (Ebit TTM 757.5m / Interest Expense TTM 322.2m)
EV/FCF = -14.87x (Enterprise Value 29.7b / FCF TTM -2.00b)
FCF Yield = -6.73% (FCF TTM -2.00b / Enterprise Value 29.7b)
FCF Margin = -50.41% (FCF TTM -2.00b / Revenue TTM 3.96b)
Net Margin = 9.18% (Net Income TTM 363.9m / Revenue TTM 3.96b)
Gross Margin = 70.67% ((Revenue TTM 3.96b - Cost of Revenue TTM 1.16b) / Revenue TTM)
Gross Margin QoQ = 75.01% (prev none%)
Tobins Q-Ratio = 1.05 (Enterprise Value 29.7b / Total Assets 28.2b)
Interest Expense / Debt = 2.26% (Interest Expense 322.2m / Debt 14.3b)
Taxrate = 15.80% (101.5m / 642.4m)
NOPAT = 637.8m (EBIT 757.5m * (1 - 15.80%))
Current Ratio = 0.61 (Total Current Assets 3.51b / Total Current Liabilities 5.73b)
Debt / Equity = 1.98 (Debt 14.3b / totalStockholderEquity, last quarter 7.21b)
Debt / EBITDA = 14.34 (Net Debt 12.2b / EBITDA 851.6m)
Debt / FCF = -6.11 (negative FCF - burning cash) (Net Debt 12.2b / FCF TTM -2.00b)
Total Stockholder Equity = 6.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.37% (Net Income 363.9m / Total Assets 28.2b)
RoE = 6.07% (Net Income TTM 363.9m / Total Stockholder Equity 6.00b)
RoCE = 3.37% (EBIT 757.5m / Capital Employed (Total Assets 28.2b - Current Liab 5.73b))
RoIC = 2.86% (NOPAT 637.8m / Invested Capital 22.3b)
WACC = 7.98% (E(17.5b)/V(31.7b) * Re(12.93%) + D(14.3b)/V(31.7b) * Rd(2.26%) * (1-Tc(0.16)))
Discount Rate = 12.93% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -4.84 | Cagr: -0.25%
[DCF] Fair Price = unknown (Cash Flow -2.00b)
EPS Correlation: 87.59 | EPS CAGR: 6.59% | SUE: 2.33 | # QB: 1
Revenue Correlation: 79.43 | Revenue CAGR: 34.17% | SUE: 0.34 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.08 | Chg30d=-0.56% | Revisions=-15% | Analysts=15
EPS current Year (2026-12-31): EPS=3.66 | Chg30d=-1.64% | Revisions=-69% | GrowthEPS=-8.9% | GrowthRev=-2.9%
EPS next Year (2027-12-31): EPS=5.11 | Chg30d=+0.26% | Revisions=+0% | GrowthEPS=+39.5% | GrowthRev=+31.7%
[Analyst] Revisions Ratio: -34% (up=11, down=24)